5
39
Growth Score
-12 pts
Heat Score
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
296480
Atrogi is a clinical-stage biotech company that treats for type 2 diabetes.
- Tore Bengtsson: Co-Founder, Chief Scientific Officer and Board Member
Giovanni Fili: Co-Founder, Investor and Board member
About the Company
Atrogi is a clinical-stage biotech company developing first-in-class, insulin-independent treatments for type 2 diabetes and related metabolic disorders, including obesity and muscle-wasting disorders.
